RxDoctor Payments Data

Lester Negron Ayala, MD

General Practice · The Villages, FLNPI 1558301275

Payments from drug & device makers

$774in general payments, 2019–2025

Across 43 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$233
  • Exact Sciences$75
  • GSK$66
  • AstraZeneca$61
  • Johnson & Johnson$60
  • Amgen$58
  • plus $222 from 10 others

What the payments were for

  • Food & beverage$774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$774 in reported general payments places this provider in the 70th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$55,587
Medicare patients
111
Services billed
640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin164$204,393
EliquisApixaban73$106,425
HumiraAdalimumab15$101,417
MounjaroTirzepatide37$52,054
TrulicityDulaglutide41$49,834
JanuviaSitagliptin Phosphate28$32,075
OzempicSemaglutide30$31,294
FarxigaDapagliflozin Propanediol12$19,577
LinzessLinaclotide15$19,242
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$17,172
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$15,244
EntrestoSacubitril/Valsartan11$14,914
Repatha SyringeEvolocumab13$6,992
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$6,044
Albuterol Sulfate HfaAlbuterol Sulfate145$6,037

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$32$204,393164 claims
PfizerEliquis$48$106,42573 claims
Lilly USA, LLCMounjaro, Trulicity$233$101,88878 claims
AstraZenecaFarxiga, Breztri Aerosphere$61$34,82127 claims
Novo NordiskOzempic$17$31,29430 claims
GSKTrelegy Ellipta$66$17,17217 claims
NovartisEntresto$21$14,91411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,901 general practice providers in Florida.

Other general practice in The Villages

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →